During the past decade, Grégoire LE GAL conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grégoire LE GAL" #1 collaborator was "University Hospital, Brest" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Swiss National Science Foundation" with 1 trials as a collaborator, "The Ottawa Hospital" with 1 trials as a collaborator and "University Hospital, Angers" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Grégoire LE GAL" are "Deep Vein Thrombosis" (2 trials), "Pulmonary Embolism" (2 trials) and "D-dimer" (1 trials). Many other conditions were trialed in "Grégoire LE GAL" in a lesser frequency.

Most popular intervention types in "Grégoire LE GAL" are "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Evaluation of a modified DD cut-off to rule out PE" (1 trials), "Pregnant patients with suspected PE will undergo a strategy based on clinical probability assessment, D-dimer, lower limb vein ultrasonography and MSCT." (1 trials) and "Three-month thromboembolic risk in patient with D-dimer levels between the usual cut-off and the age-adjusted cut-off" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grégoire LE GAL" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Grégoire LE GAL". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Grégoire LE GAL, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grégoire LE GAL, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".